Dr Paula Franklin, currently Chief Medical and Risk Officer for Bupa Global & UK, will take up leadership of the global medical function from 1 August alongside her responsibilities for the Bupa Global & UK market unit. Paula will report into David Fletcher, Group Chief Risk Officer, and join the Bupa Executive Team.
Dr Paul Zollinger-Read CBE, who has been Bupa’s Chief Medical Officer since 2012, will step down on 31 July.
Group CEO Evelyn Bourke said: “Paula is an excellent addition to the Bupa Executive Team. She has a strong track record of clinical governance and risk leadership in Bupa Global and the UK and I am delighted that she has agreed to lead our global medical function.”
“I would like to thank Paul for all he has achieved at Bupa. He has had a long and distinguished medical career and we have very much valued his contribution, especially the way he has championed the voice of clinicians within Bupa.”